AP Pharma Inc /DE/

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
AP Pharma Inc /DE/
CIK #0000818033
EDGAR Form CIK 2011 - 2026
10-K [0000818033]
10-Q [0000818033]
3 [0000818033]
4 [0000818033]
5 [0000818033]
8-K [0000818033]
D [0000818033]
SC 13D [0000818033]
SC 13G [0000818033]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Group Inc Heron Therapeutics Inc /DE/ [2026-01-30]
Clearline Capital LP Heron Therapeutics Inc /DE/ [2025-11-26]
Adage Capital Management LP Heron Therapeutics Inc /DE/ [2024-11-12]
BlackRock Inc Heron Therapeutics Inc /DE/ [2024-11-08]
BlackRock Inc Heron Therapeutics Inc /DE/ [2024-10-24]
Great Point Partners LLC Heron Therapeutics Inc /DE/ [2023-04-13]
Rubric Capital Management LP Heron Therapeutics Inc /DE/ [2023-02-06]
Deep Track Capital LP Heron Therapeutics Inc /DE/ [2022-08-19]
UBS OConnor LLC Heron Therapeutics Inc /DE/ [2022-02-14]
State Street Corp Heron Therapeutics Inc /DE/ [2022-02-11]
View All
Form 3/4/5 Subject 2011 - 2026
Heron Therapeutics Inc /DE/
Duarte Ira
Forbes William P
Hensley Mark Earl
Collard Craig A
Christian Waage
Morgan Adam
Dissanaike Sharmila
Cusack Thomas
Johnson Craig A
Kaseta Michael
Rosen David Efraim
Rubric Capital Management LP
Rodriguez Susan
Peraza Lisa
Szekeres David Leslie
Manhard Kimberly
Poyhonen John
Kotler Kevin
Velan Capital Investment Management LP
Venkataraman Balaji
Velan Capital Management LLC
Velan Capital Master Fund LP
Velan Capital Holdings LLC
Quart Barry D
Davis Stephen
Tang Kevin
Hoffman Robert
Rosen Robert
Tang Capital Management LLC
Tang Capital Partners LP
Drazba Brian G
Marshall Paul
Clendeninn Neil James
SPCH LLC
Midler Andrew R
Savitr Capital LLC
Gelder Mark S MD
Whelan John
Adam Michael A
Turnbull Greg
Goddard Paul
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Heron Therapeutics Inc /DE/ HRTX
Restricted Stock Units · derivative
2026-01-31 Option exercise 11,695 $0.00
Heron Therapeutics Inc /DE/ HRTX
Common Stock
2026-01-31 Option exercise 11,695
Heron Therapeutics Inc /DE/ HRTX
Common Stock
2026-01-31 Option exercise 34,789
Heron Therapeutics Inc /DE/ HRTX
Restricted Stock Units · derivative
2026-01-31 Option exercise 34,789 $0.00
Heron Therapeutics Inc /DE/ HRTX
Restricted Stock Units · derivative
2026-01-31 Option exercise 11,695 $0.00
Heron Therapeutics Inc /DE/ HRTX
Common Stock
2026-01-31 Option exercise 11,695
Heron Therapeutics Inc /DE/ HRTX
Performance Stock Units · derivative
2026-01-30 Grant 188,314 $0.00
Heron Therapeutics Inc /DE/ HRTX
Common Stock
2026-01-30 Grant 53,960 $0.00
Heron Therapeutics Inc /DE/ HRTX
Restricted Stock Units · derivative
2026-01-30 Grant 188,315 $0.00
Heron Therapeutics Inc /DE/ HRTX
Common Stock
2026-01-30 Grant 53,960 $0.00
Heron Therapeutics Inc /DE/ HRTX
Common Stock
2026-01-30 Grant 53,960 $0.00
Heron Therapeutics Inc /DE/ HRTX
Common Stock
2026-01-30 Grant 53,960 $0.00
Heron Therapeutics Inc /DE/ HRTX
Performance Stock Units · derivative
2026-01-30 Grant 800,336 $0.00
Heron Therapeutics Inc /DE/ HRTX
Restricted Stock Units · derivative
2026-01-30 Grant 188,315 $0.00
Heron Therapeutics Inc /DE/ HRTX
Restricted Stock Units · derivative
2026-01-30 Grant 216,562 $0.00
Heron Therapeutics Inc /DE/ HRTX
Performance Stock Units · derivative
2026-01-30 Grant 216,561 $0.00
Heron Therapeutics Inc /DE/ HRTX
Restricted Stock Units · derivative
2026-01-30 Grant 800,337 $0.00
Heron Therapeutics Inc /DE/ HRTX
Common Stock
2026-01-30 Grant 53,960 $0.00
Heron Therapeutics Inc /DE/ HRTX
Common Stock
2026-01-30 Grant 53,960 $0.00
Heron Therapeutics Inc /DE/ HRTX
Performance Stock Units · derivative
2026-01-30 Grant 188,314 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com